RankAlpha logo
Back to Rankings

TCRX

TScan TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
TCRX vs peer average
22/100
TCRX vs. peer average (F vs. C)
Grade spread
A 2 · B 1 · C 1 · D 1 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CING is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $61.42M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCINGCingulate
TCRX
TScan Therapeutics
CING
Cingulate
Grade
F
C
Momentum
10
13
Value
41
41
Sentiment
-
100
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs CING

TCRX / CING
Grade Position
Below peers
TCRX vs. peer average (F vs. C)
22/100
Momentum
10
CING
Value
41
TCRX
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs TCRX
1
CING
Cingulate Inc Common
C
60/100
-2
2
TELO
Telomir Pharmaceuticals Inc Common
F
20/100
Even
3
CRDF
Cardiff Oncology Inc Common
A
100/100
-4
4
CNTX
Context Therapeutics Inc Common
A
100/100
-4
5
INCR
InterCure Ltd Common
B
80/100
-3
CING is the first peer returned for this comparison set.